Beatriz Calle Serrano

838 total citations
9 papers, 605 citations indexed

About

Beatriz Calle Serrano is a scholar working on Hepatology, Epidemiology and Rheumatology. According to data from OpenAlex, Beatriz Calle Serrano has authored 9 papers receiving a total of 605 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hepatology, 8 papers in Epidemiology and 1 paper in Rheumatology. Recurrent topics in Beatriz Calle Serrano's work include Hepatitis C virus research (9 papers), Hepatitis B Virus Studies (8 papers) and Liver Disease Diagnosis and Treatment (7 papers). Beatriz Calle Serrano is often cited by papers focused on Hepatitis C virus research (9 papers), Hepatitis B Virus Studies (8 papers) and Liver Disease Diagnosis and Treatment (7 papers). Beatriz Calle Serrano collaborates with scholars based in Germany, United States and Poland. Beatriz Calle Serrano's co-authors include Michael P. Manns, Heiner Wedemeyer, Markus Cornberg, Katja Deterding, R. Raupach, Robert Flisiak, C.–Thomas Bock, Jérôme Schlué, Karsten Wursthorn and Jerzy Jaroszewicz and has published in prestigious journals such as PLoS ONE, Hepatology and Journal of Hepatology.

In The Last Decade

Beatriz Calle Serrano

9 papers receiving 587 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Beatriz Calle Serrano Germany 7 568 561 51 24 16 9 605
Zunaira Awan Pakistan 10 261 0.5× 277 0.5× 49 1.0× 22 0.9× 39 2.4× 15 343
Chia Wang United States 6 345 0.6× 364 0.6× 58 1.1× 72 3.0× 10 0.6× 11 450
U. Oesen Germany 6 471 0.8× 497 0.9× 27 0.5× 40 1.7× 15 0.9× 7 533
J Cianciara Poland 10 289 0.5× 289 0.5× 50 1.0× 18 0.8× 18 1.1× 35 328
A. Guastadisegni Italy 5 477 0.8× 487 0.9× 63 1.2× 13 0.5× 10 0.6× 10 504
D. Perner Germany 9 315 0.6× 355 0.6× 108 2.1× 18 0.8× 39 2.4× 22 390
Watcharasak Chotiyaputta Thailand 13 555 1.0× 546 1.0× 106 2.1× 15 0.6× 22 1.4× 30 623
Friederike Zahm Switzerland 7 525 0.9× 533 1.0× 23 0.5× 16 0.7× 11 0.7× 12 573
Anika Wranke Germany 12 387 0.7× 398 0.7× 26 0.5× 19 0.8× 18 1.1× 20 443
Cecilia Marrocco Italy 11 454 0.8× 466 0.8× 65 1.3× 11 0.5× 9 0.6× 15 500

Countries citing papers authored by Beatriz Calle Serrano

Since Specialization
Citations

This map shows the geographic impact of Beatriz Calle Serrano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beatriz Calle Serrano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beatriz Calle Serrano more than expected).

Fields of papers citing papers by Beatriz Calle Serrano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beatriz Calle Serrano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beatriz Calle Serrano. The network helps show where Beatriz Calle Serrano may publish in the future.

Co-authorship network of co-authors of Beatriz Calle Serrano

This figure shows the co-authorship network connecting the top 25 collaborators of Beatriz Calle Serrano. A scholar is included among the top collaborators of Beatriz Calle Serrano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Beatriz Calle Serrano. Beatriz Calle Serrano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Wranke, Anika, Beatriz Calle Serrano, Benjamin Heidrich, et al.. (2016). Antiviral treatment and liver‐related complications in hepatitis delta. Hepatology. 65(2). 414–425. 77 indexed citations
2.
Maasoumy, Benjamin, Kerstin Port, Antoaneta A. Markova, et al.. (2013). Eligibility and Safety of Triple Therapy for Hepatitis C: Lessons Learned from the First Experience in a Real World Setting. PLoS ONE. 8(2). e55285–e55285. 81 indexed citations
3.
Serrano, Beatriz Calle & Michael P. Manns. (2012). HCV’s days are numbered: next-generation direct-acting antivirals and host-targeting agents. Antiviral Therapy. 17(6 Pt B). 1133–1146. 4 indexed citations
4.
Heidrich, Benjamin, Beatriz Calle Serrano, Ramazan Idılman, et al.. (2012). HBeAg‐positive hepatitis delta: virological patterns and clinical long‐term outcome. Liver International. 32(9). 1415–1425. 45 indexed citations
5.
Serrano, Beatriz Calle & Michael P. Manns. (2012). Telaprevir and Boceprevir: The Future Is Now. TECNALIA Publications (Fundación TECNALIA Research & Innovation). 11(3). 160–171. 2 indexed citations
6.
Serrano, Beatriz Calle, Michael P. Manns, & Heiner Wedemeyer. (2012). Hepatitis Delta and HIV Infection. Seminars in Liver Disease. 32(2). 120–129. 18 indexed citations
7.
Manns, Michael P., Antoaneta A. Markova, Beatriz Calle Serrano, & Markus Cornberg. (2011). Phase III results of Boceprevir in treatment naïve patients with chronic hepatitis C genotype 1. Liver International. 32(s1). 27–31. 23 indexed citations
8.
Jaroszewicz, Jerzy, Beatriz Calle Serrano, Karsten Wursthorn, et al.. (2010). Hepatitis B surface antigen (HBsAg) levels in the natural history of hepatitis B virus (HBV)-infection: A European perspective. Journal of Hepatology. 52(4). 514–522. 325 indexed citations
9.
Ruíz-Moreno, M, Rosa García, Beatriz Calle Serrano, et al.. (1993). Levamisole and interferon in children with chronic hepatitis B. Hepatology. 18(2). 264–269. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026